Influenza Efficacy Models

Influenza viruses (INFV) are segmented RNA viruses that cause seasonal influenza epidemics and pandemics. IBT Bioservices with a well-equipped, modern IACUC certified facility with expert scientists can help you develop Influenza Efficacy Models

Influenza A can infect and be transmitted between birds and some mammals (e.g. pigs and humans). Influenza B only infects humans and seals. Influenza infection poses a severe threat to public health and the agricultural economy. This virus mutates quickly by both antigenic drift and reassortment requiring the development and reformulation of new vaccines each year. Influenza strains resistant to almost all known drugs have been identified, making drug development a critical pursuit.
Concerns about INFV infection are further heightened by the potential for transmission of highly pathogenic avian strains (HPAI) to humans. IBT Bioservices has developed several mouse models of Influenza infection wherein mice are inoculated intranasally with an LD90 dose of virus.

KEY FEATURES

Animal Background: Challenge Route: Peak Lesion Size: Standard Readouts:

BALB/C, CD-1

Intradermal (ID)

Strain dependent

Weights, health, survival, lesions, photographs

Other Readouts:

Bacterial Assays (MIC), ELISA, Luminex, Flow cytometry

Subtype/Lineage

  • A(H1N1)
  • A(H1N1)
  • A(H1N1)
  • A(H1N1)
  • A(H3N2)
  • A(H3N2)
  • Yamagata Lineage
  • Victoria Lineage

Virus Strain

  • A/Texas/36/91
  • A/PUERTO RICO/8/34
  • A/Perth/261/2009 (H25Y) Tamiflu Resistant
  • A/California/07/09
  • A/Hong Kong/01/68
  • A/VICTORIA/03/75
  • B/Florida/04/06
  • B/Brisbane/60/09

Search
Generic filters

Choice Billing Address

×

You have no billing addresses.

Choice Shipping Address

×